Gastroenterology and Liver

Autoimmune Liver Disorders

Autoimmune liver disorders, including autoimmune hepatitis, primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC), present unique diagnostic and therapeutic challenges. This session will explore the immunopathogenesis, genetic predisposition, and clinical features of these conditions. Advances in diagnostic strategies, including serological markers, imaging techniques, and histopathology, will be presented to facilitate early and accurate diagnosis. Treatment approaches, ranging from immunosuppressive therapies to emerging biologics, will be discussed with a focus on optimizing patient outcomes and minimizing adverse effects.

In addition, this track highlights long-term management, monitoring for disease progression, and strategies for managing complications such as cirrhosis and liver failure. Case studies, clinical trial findings, and translational research will provide attendees with practical insights and evidence-based approaches. Discussions on personalized care, patient-centered management, and future research directions will foster collaboration and encourage abstract submissions in this evolving field. This session is designed for hepatologists, immunologists, researchers, and allied healthcare professionals engaged in autoimmune liver disease management.